RxDoctor Payments Data

Deanne Threapleton

Nurse Practitioner · Nashville, TNNPI 1851688865

Payments from drug & device makers

$9,248in general payments, 2019–2025

Across 407 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$965
  • Collegium Pharmaceutical, Inc.$801
  • Biohaven Pharmaceuticals, Inc.$712
  • AbbVie$687
  • Pfizer$590
  • plus $4K from 27 others

What the payments were for

  • Food & beverage$9,248100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,248 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$95,376
Medicare patients
104
Services billed
1,267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate31$44,552
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,443$40,233
Xtampza ErOxycodone Myristate97$39,887
Aimovig AutoinjectorErenumab-Aooe48$35,473
RelistorMethylnaltrexone Bromide13$32,467
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen972$30,654
ZilrettaTriamcinolone Acetonide27$21,510
ZtlidoLidocaine22$13,542
Lidocaine237$12,363
MovantikNaloxegol Oxalate24$9,660
Gabapentin879$8,903
SymproicNaldemedine Tosylate12$5,273
Tizanidine Hcl361$4,905
Pregabalin250$4,678
Diclofenac Sodium177$4,035

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$590$44,55231 claims
Collegium Pharmaceutical, Inc.Xtampza Er$801$39,88797 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$965$32,46713 claims
Pacira Pharmaceuticals IncorporatedZilretta$274$21,51027 claims
Scilex Pharmaceuticals Inc.Ztlido$371$13,54222 claims
Virtus Pharmaceuticals LLCLactulose$15$12913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →